BMY is up 0.21% today. Volume is 7.75M vs a 30-day average of 13.54M (0.57x).
Bristol-Myers Squibb Company is scheduled to report earnings Thu, Oct 29, 2026 · before open. Analysts expect EPS of $1.21 on revenue of about $12.87B. Stocks often move sharply on earnings day.
Bristol Myers Squibb (NYSE:BMY) reported interim Phase 1 Breakfree-2 data on zola-cel CAR T therapy in multiple sclerosis. The readout showed early efficacy signals, including com…
See how the Best Dividend Stocks screen balances high yield with profitability and health, using Bristol-Myers Squibb as a dividend case study.
Piper Sandler analyst David Amsellem maintains Bristol-Myers Squibb (NYSE:BMY) with a Overweight and lowers the price target from $82 to $78.
Bristol Myers Squibb (NYSE:BMY) has entered multi year AI drug development partnerships with Pathos AI and Tempus AI. The agreement gives Bristol Myers Squibb exclusive access to …
Bristol Myers Squibb (BMY) reached $61.48 at the closing of the latest trading day, reflecting a -2.41% change compared to its last close.